LeMaitre Vascular to Participate in Two Investor Conferences in March
Get Alerts LMAT Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.4%
Revenue Growth %: +11.0%
Join SI Premium – FREE
BURLINGTON, Mass., March 01, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that it will be participating in two investor conferences in March.
David Roberts, President, is scheduled to present at the 28th Annual ROTH Conference at the Ritz-Carlton, Laguna Niguel, CA on Tuesday, March 15, 2016. The company presentation is scheduled to begin at 12:00 pm PDT.
JJ Pellegrino, CFO, is scheduled to present at the Sidoti Emerging Growth Conference at the Marriott Marquis, New York City on Thursday, March 31, 2016.
For more information or to register, please visit the conference websites at www.roth.com and www.sidoti.com.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Sandra Millar +1-781-425-1686 [email protected] http://www.lemaitre.comSource: LeMaitre Vascular, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MissionIRNewsBreaks – Rezolve Ai (NASDAQ: RZLV) Reports H1 Revenue of $130.8 Million, Reaffirms 2026 Guidance
- D-Orbit Selects GomSpace Power Systems for Upcoming Space Logistics Missions
- A Developer Just Set Terms for Buying Up to 1,500 Factory-Built Homes, and It Signals Where Housing May Be Headed
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Sidoti & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share